Treatment end point determinants for pulmonary tuberculosis: Human resistin as a surrogate biomarker

Tuberculosis

Volumn 91, Issue 4, 2011, Pages 293-299

  Ehtesham, Nasreen Z ^a,b   Nasiruddin, Mohammad ^b   Alvi, Ayesha ^a   Kumar, Battula K ^b   Ahmed, Niyaz ^a,c   Peri, Sundaresh ^d   Murthy, Kolluri J R ^e   Hasnain, Seyed E ^a,f,g  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

^c UNIVERSITY OF HYDERABAD   (India)

^d LEPRA Society   (India)

^e Mahavir Hospital and Research Centre   (India)

^f INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^g INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Hepatotoxicity; Pulmonary tuberculosis; Resistin; Surrogate marker

Indexed keywords

C REACTIVE PROTEIN; RESISTIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL LOAD; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; BODY WEIGHT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENDPOINT DETERMINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESISTIN; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 79960260454     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.04.007     Document Type: Article

References (38)

1. Global tuberculosis control: surveillance, planning, financing: WHO report 2008 http://www.who.int/tb/publications/global-report/2008/pdf/ fullreport.pdf [accessed 04.13.10]
2. M.C. Gutierrez, N. Ahmed, E. Willery, S. Narayanan, S.E. Hasnain, and D.S. Chauhan Predominance of ancestral lineages of Mycobacterium tuberculosis in India Emerg Infect Dis 12 2006 1367 1374 (Pubitemid 44462680)
3. A. Tostmann, M.J. Boeree, R.E. Aarnoutse, W.C. de Lange, A.J. van der Ven, and R. Dekhuijzen Antituberculosis drug-induced hepatotoxicity: concise up-to-date review J Gastroenterol Hepatol 23 2008 192 202 (Pubitemid 351257678)
4. S.K. Sharma Antituberculosis drugs and hepatotoxicity Infect Genet Evol 4 2004 167 170 (Pubitemid 38647301)
5. G. Walzl, R. Katharina, J.F.D. Siawaya, and H.M. Dockrell Biomarkers for TB treatment response: challenges and future strategies J Infect 57 2008 103 109
6. J. Almirall, I. Bolibar, P. Toran, G. Pera, X. Boquet, and X. Balanzo Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Chest 125 2004 1335 1342 (Pubitemid 38501347)
7. R. Baynes, W. Bezwoda, T. Bothwell, Q. Khan, and N. Mansoor The nonimmune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein Scand J Clin Lab Invest 46 1986 695 704 (Pubitemid 17171522)
8. J.H. Lee, and J.H. Chang Changes of plasma interleukin-1receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis Korean J Intern Med 18 2003 138 145
9. M.L. Plit, R. Anderson, C.E. Van Rensburg, L. Page-Shipp, J.A. Blott, and J.L. Fresen Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis Eur Respir J 12 1998 351 356 (Pubitemid 28389528)
10. G. Bajaj, A. Rattan, and P. Ahmad Prognostic value of 'C' reactive protein in tuberculosis Indian Pediatr 26 1989 1010 1013
11. N. Silswal, A.K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, and N.Z. Ehtesham Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway Biochem Biophys Res Commun 334 2005 1092 1101 (Pubitemid 41074686)
12. M. Filková, M. Haluzík, S. Gay, and L. Senolt The role of resistin as a regulator of inflammation: implications for various human pathologies Clin Immunol 133 2009 157 170
13. J.L. Fargnoli, Q. Sun, D. Olenczuk, L. Qi, Y. Zhu, and F.B. Hu Resistin is associated with biomarkers of inflammation while total and highmolecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function Eur J Endocrinol 162 2010 281 288
14. A. Karbowska, M. Boratyńska, and M. Klinger Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation? Postepy Hig Med Dosw 63 2009 485 491
15. J. Sundén-Cullberg, T. Nyström, M.L. Lee, G.E. Mullins, L. Tokics, and J. Andersson Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock Crit Care Med 35 2007 1536 1542 (Pubitemid 46809318)
16. N. Holcomb, R.C. Kabakoff, B. Chan, T.W. Baker, A. Gurney, and W. Henzel FIZZ1 a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family EMBO J 19 2000 4046 4055 (Pubitemid 30608543)
17. S.S. Pang, and Y.Y. Le Role of resistin in inflammation and inflammationrelated diseases Cell Mol Immunol 3 2006 29 34
18. M.P. Reilly, M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, and D.J. Rader Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 2005 932 939 (Pubitemid 40279897)
19. K. Migita, Y. Maeda, T. Miyashita, H. Kimura, M. Nakamura, and H. Ishibashi The serum levels of resistin in rheumatoid arthritis patients Clin Exp Rheumatol 24 2006 698 701 (Pubitemid 46138804)
20. K. Karmiris, I.E. Kautroubakis, C. Xidakis, M. Polychronaki, T. Voudouri, and E.A. Kauroumalis Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease Inflamm Bowel Dis 12 2006 100 105
21. L. Senolt, D. Housa, Z. Vernerová, T. Jirásek, R. Svobodová, and D. Veigl Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum Ann Rheum Dis 66 2007 458 463 (Pubitemid 46580464)
22. I. Nagaev, M. Bokarewa, A. Tarkowski, and U. Smith Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes PLoS One 1 2006 e31
23. L. Johansson, A. Linnér, J. Sundén-Cullberg, A. Haggar, H. Herwald, and K. Loré Neutrophil-derived hyperresistinemia in severe acute streptococcal infections J Immunol 183 2009 4047 4054
24. L.S. Chauhan Status report on RNTCP Indian J Tuberc 56 2009 213 216
25. S.H.E. Kaufmann, and S.K. Parida Tuberculosis in Africa: learning from pathogenesis for biomarker identification Cell Host Microbe 4 2008 219 228
26. S.H.E. Kaufmann, and S.K. Parida The quest for biomarkers in tuberculosis Drug Discov Today 15 2010 148 157
27. S. Rao, and V. Bernhardt Serum C-reactive protein in pulmonary tuberculosis: correlation with bacterial load and extent of disease Infect Dis Clin Pract 17 2009 314 316
28. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
29. C. Bertolani, and F. Marra The role of adipokines in liver fibrosis Pathophysiology 15 2008 91 101
30. J.I. Beier, L. Guo, C. von Montfort, J.P. Kaiser, S. Joshi-Barve, and G.E. Arteel New role of resistin in lipopolysaccharide-induced liver damage in mice J Pharmacol Exp Ther 325 2008 801 808 (Pubitemid 351724330)
31. C.S. Hirsch, Z. Toossi, C. Othieno, J.L. Johnson, S.K. Schwander, and S. Robertson Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy J Infect Dis 180 1999 2069 2073
32. S. Ribeiro, K. Dooley, J. Hackman, C. Loredo, A. Efron, and R.E. Chaisson T-SPOT.TB responses during treatment of pulmonary tuberculosis BMC Infect Dis 9 2009 23
33. A. Tarkowski, J. Bjersing, A. Shestakov, and M.I. Bokarewa Resistin competes with lipopolysaccharide for binding to toll like receptor 4 J Cell Mol Med 20 2009 1 13
34. R.K. Choudhary, S. Mukhopadhyay, P. Chakhaiyar, N. Sharma, K.J. Murthy, and V.M. Katoch PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response Infect Immun 71 2003 6338 6343 (Pubitemid 37337691)
35. P. Chakhaiyar, Y. Nagalakshmi, B. Aruna, K.J.R. Murthy, V.M. Katoch, and S.E. Hasnain Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open reading frame, Rv2608 show a differential humoral response and a low T cell response in various categories of patients with tuberculosis J Infect Dis 190 2004 1237 1244 (Pubitemid 39287749)
36. S. Banerjee, A. Nandyala, R. Podili, V.M. Katoch, K.J.R. Murthy, and S.E. Hasnain Mycobacterium tuberculosis(Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients Proc Nat Acad Sci U S A 101 2004 12652 12657 (Pubitemid 39122078)
37. S. Tundup, N. Pathak, M. Ramanadham, S. Mukhopadhyay, K.J. Murthy, and N.Z. Ehtesham The Co-operonic PE25/PPE41 p.otein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response PLoS One 3 2008 e3586
38. N. Bashir, F. Kounsar, S. Mukhopadhyay, and S.E. Hasnain Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions Immunology 130 2010 34 45